ניו זילנד - אנגלית - Medsafe (Medicines Safety Authority)

abbvie limited - leuprorelin acetate 3.75mg (powder for injection compartment) - injection (depot) - 3.75 mg - active: leuprorelin acetate 3.75mg (powder for injection compartment) excipient: acetic acid carmellose sodium gelatin plga (copoly (dl-lactic acid/glycolic acid) 75:25mol%) powder for injection compartment mannitol polysorbate 80 water for injection - lucrin (leuprorelin acetate) is indicated · in metastatic prostate cancer · in locally advanced prostate cancer, as an alternative to surgical castration · as an adjuvant treatment to radiotherapy in patients with high-risk localized or locally advanced prostate cancer · as an adjuvant treatment to radical prostatectomy in patients with locally advanced prostate cancer at high risk of disease progression

ניו זילנד - אנגלית - Medsafe (Medicines Safety Authority)

abbvie limited - leuprorelin acetate 11.25mg (powder for injection compartment) - injection (depot) - 11.25 mg - active: leuprorelin acetate 11.25mg (powder for injection compartment) excipient: carmellose sodium glacial acetic acid polylactic acid (pla) powder for injection compartment mannitol polysorbate 80 water for injection - lucrin (leuprorelin acetate) is indicated · in metastatic prostate cancer · in locally advanced prostate cancer, as an alternative to surgical castration · as an adjuvant treatment to radiotherapy in patients with high-risk localized or locally advanced prostate cancer · as an adjuvant treatment to radical prostatectomy in patients with locally advanced prostate cancer at high risk of disease progression

ניו זילנד - אנגלית - Medsafe (Medicines Safety Authority)

abbvie limited - palivizumab 100mg (;+overage = 122mg/vial) - injection with diluent - 100 mg - active: palivizumab 100mg (;+overage = 122mg/vial) excipient: glycine histidine mannitol nitrogen transferrin water for injection - synagis is indicated for the prevention of serious lower respiratory tract disease caused by respiratory syncytial virus (rsv) in children at high risk of rsv disease. safety and efficacy were established in children with bronchopulmonary dysplasia (bpd), infants with a history of prematurity (gestational age < 35 weeks at birth) and children with haemodynamically significant congenital heart disease (chd).

ניו זילנד - אנגלית - Medsafe (Medicines Safety Authority)

abbvie limited - palivizumab 50mg (;+ overage = 73mg/vial) - injection with diluent - 50 mg - active: palivizumab 50mg (;+ overage = 73mg/vial) excipient: glycine histidine mannitol nitrogen water for injection - synagis is indicated for the prevention of serious lower respiratory tract disease caused by respiratory syncytial virus (rsv) in children at high risk of rsv disease. safety and efficacy were established in children with bronchopulmonary dysplasia (bpd), infants with a history of prematurity (gestational age < 35 weeks at birth) and children with haemodynamically significant congenital heart disease (chd).

אירלנד - אנגלית - HPRA (Health Products Regulatory Authority)

abbvie limited - brimonidine tartrate; timolol maleate - eye drops, solution - beta blocking agents1); timolol, combinations

אירלנד - אנגלית - HPRA (Health Products Regulatory Authority)

abbvie limited - carmellose sodium - eye drops, solution - other ophthalmologicals; artificial tears and other indifferent preparations

אירלנד - אנגלית - HPRA (Health Products Regulatory Authority)

abbvie limited - carmellose sodium - eye drops, solution - other ophthalmologicals; artificial tears and other indifferent preparations

אירלנד - אנגלית - HPRA (Health Products Regulatory Authority)

abbvie limited - isoflurane - inhalation gas - 99.9 percent weight/weight - halogenated hydrocarbons; isoflurane

מלטה - אנגלית - Medicines Authority

abbvie limited citywest business campus, dublin 24, ireland - powder for solution for injection - botulinum toxin type a 100 allergan units/0.1 millilitre - muscle relaxants

מלטה - אנגלית - Medicines Authority

abbvie limited citywest business campus, dublin 24, ireland - powder for solution for injection - botulinum toxin type a 50 allergan units/0.1 millilitre - muscle relaxants